107 related articles for article (PubMed ID: 2986983)
1. Immunofluorescence detection of liver cell membrane autoantibodies using PLC/PRF/5 cells.
de Koning RW; Daemen M; Schutte B; Geertzen HG; Blijham GH; Bosman FT
Eur J Clin Invest; 1985 Apr; 15(2):64-8. PubMed ID: 2986983
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of Liver membrane autoantibodies determined by indirect immunofluorescence.
Tage-Jensen U; Permin H; Krogsgaard K
J Clin Pathol; 1982 Mar; 35(3):315-8. PubMed ID: 6802881
[TBL] [Abstract][Full Text] [Related]
3. Detection of HBsAg in a clone derived from the PLC/PRF/5 human hepatoma cell line.
Wen YM; Copeland JA; Mann GF; Howard CR; Zuckerman AJ
Arch Virol; 1981; 68(3-4):157-63. PubMed ID: 6268017
[TBL] [Abstract][Full Text] [Related]
4. Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.
Lobo-Yeo A; McSorley C; McFarlane BM; Mieli-Vergani G; Mowat AP; Vergani D
Hepatology; 1989 Feb; 9(2):210-4. PubMed ID: 2536348
[TBL] [Abstract][Full Text] [Related]
5. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
Imai H; Nakano Y; Kiyosawa K; Tan EM
Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of antibody to liver cell membrane in sera from patients with chronic active liver diseases.
Tsuji T; Araki K; Naito K; Inoue J; Nacashima H
Acta Med Okayama; 1979 Feb; 33(1):61-6. PubMed ID: 220848
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of complement-fixing antinuclear antibodies in patients with hepatocellular carcinoma.
Kiyosawa K; Daemer RJ; He LF; Bonino F; Prozesky OW; Purcell RH
Hepatology; 1985; 5(4):548-55. PubMed ID: 2991105
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte plasma membrane antigens. I. Determination of antibodies bound to the hepatocyte plasma membrane by 125I-protein A binding assay.
Sakaguchi K
Gastroenterol Jpn; 1983 Aug; 18(4):330-8. PubMed ID: 6313464
[TBL] [Abstract][Full Text] [Related]
9. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells.
Wiedmann KH; Trejdosiewicz LK; Southgate J; Thomas HC
Hepatology; 1987; 7(3):543-50. PubMed ID: 2437001
[TBL] [Abstract][Full Text] [Related]
10. Liver membrane autoantibodies in chronic active hepatitis. Studies on mechanically and enzymatically isolated rabbit hepatocytes.
Gerken G; Manns M; Ramadori G; Poralla T; Dienes HP; Meyer zum Büschenfelde KH
J Hepatol; 1987 Aug; 5(1):65-74. PubMed ID: 3655312
[TBL] [Abstract][Full Text] [Related]
11. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
Shao RP
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):259-61. PubMed ID: 3019621
[TBL] [Abstract][Full Text] [Related]
12. Liver membrane autoantibodies: methods for their detection and clinical significance.
Nagai S; Manns M; Meyer zum Büschenfelde KH
Tokai J Exp Clin Med; 1982 Mar; 7(2):145-58. PubMed ID: 7048633
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo tumour localisation with a monoclonal antibody directed against a membrane antigen on the human hepatocellular carcinoma cell line PLC/PRF/5.
Dunk AA; Brown D; Weidmann K; Thomas HC
J Hepatol; 1987 Feb; 4(1):52-61. PubMed ID: 3033060
[TBL] [Abstract][Full Text] [Related]
14. Rabbit antibodies to nucleoli of Novikoff hepatoma and normal liver of the rat.
Busch RK; Daskal I; Spohn WH; Kellermayer M; Busch H
Cancer Res; 1974 Sep; 34(9):2362-7. PubMed ID: 4367290
[No Abstract] [Full Text] [Related]
15. Distribution patterns of hepatitis B antigen in the liver. Immunofluorescence studies.
Akeyama T; Kamada T; Koyama M; Abe H
Arch Pathol; 1974 Oct; 98(4):252-6. PubMed ID: 4369930
[No Abstract] [Full Text] [Related]
16. Detection of membrane-bound alpha-fetoprotein in human hepatoma cell lines by monoclonal antibody 19F12.
Hosokawa S; Muramatsu M; Nagaike K
Cancer Res; 1989 Jan; 49(2):361-6. PubMed ID: 2463075
[TBL] [Abstract][Full Text] [Related]
17. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
Hopf U; Meyer zum Büschenfelde KH; Arnold W
N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
[TBL] [Abstract][Full Text] [Related]
18. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients.
Chen YM; Hu CP; Chen PH; Chu MH; Tsai YT; Lee SD; Chang CM
Hepatology; 1988; 8(3):547-52. PubMed ID: 2836290
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in the sera and ascites of hepatocellular carcinoma or chronic hepatitis patients.
Chen YM; Hu CP; Wong FH; Chen PH; Tsai YT; Lee SD; Liu JD; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1986 Feb; 19(1):34-45. PubMed ID: 3028719
[TBL] [Abstract][Full Text] [Related]
20. Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.
Meliconi R; Stancari MV; Garagnani M; Baraldini M; Stefanini GF; Miglio F; Gasbarrini G
Clin Exp Immunol; 1983 Mar; 51(3):565-71. PubMed ID: 6342885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
